|
|
|
|
Transparency and communication are essential to the success of a manufacturing partnership. If a CDMO is unwilling to have frank conversations during the proposal phase, that’s likely a red flag. The right partner’s team will help you make educated choices while ensuring quality, reasonable costs, and timeline efficiency.
|
|
|
|
|
Tech Transfer for biologic medicinal products is complex - filled with potential pitfalls, hazards, and breakpoints. Precision manufacturing must be coupled with speed to optimize processes and minimize risk. Review strategies and methodologies for seamless technology transfer to your CDMO through the lens of real-world case studies.
|
|
|
|
|
In 2023, 18 new biologic drugs were approved by the EMA and 34 by the FDA. These drugs cover a wide range of therapeutic areas — including protein vaccines, BsAbs, and gene therapy — and utilize innovative technologies. Dive into the 10 most important drugs that cover unmet medical needs and have the potential to revolutionize medical practice.
|
|
|
|
|
Novavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a reliable partner providing manufacturing and analytical services. Learn how a CDMO with the right experience and capabilities is crucial to support accelerated GMP manufacturing and ensure novel vaccines and therapeutics receive regulatory approval.
|
|
|
|
|
|
|
